These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 38169585)

  • 1. Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors.
    Zheng K; Feng Y; Li L; Kong F; Gao J; Kong X
    Theranostics; 2024; 14(2):761-787. PubMed ID: 38169585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis.
    Li Q; Zhou G; Fei X; Tian Y; Wang S; Shi H
    Appl Environ Microbiol; 2023 Mar; 89(3):e0204722. PubMed ID: 36809058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outer membrane vesicles (OMVs) enabled bio-applications: A critical review.
    Huang Y; Nieh MP; Chen W; Lei Y
    Biotechnol Bioeng; 2022 Jan; 119(1):34-47. PubMed ID: 34698385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial outer membrane vesicles as a candidate tumor vaccine platform.
    Wang S; Guo J; Bai Y; Sun C; Wu Y; Liu Z; Liu X; Wang Y; Wang Z; Zhang Y; Hao H
    Front Immunol; 2022; 13():987419. PubMed ID: 36159867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial outer membrane vesicles as potential biological nanomaterials for antibacterial therapy.
    Huang W; Meng L; Chen Y; Dong Z; Peng Q
    Acta Biomater; 2022 Mar; 140():102-115. PubMed ID: 34896632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial outer membrane vesicles as a platform for biomedical applications: An update.
    Li M; Zhou H; Yang C; Wu Y; Zhou X; Liu H; Wang Y
    J Control Release; 2020 Jul; 323():253-268. PubMed ID: 32333919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering Versatile Bacteria-Derived Outer Membrane Vesicles: An Adaptable Platform for Advancing Cancer Immunotherapy.
    Luo Z; Cheng X; Feng B; Fan D; Liu X; Xie R; Luo T; Wegner SV; Ma D; Chen F; Zeng W
    Adv Sci (Weinh); 2024 Sep; 11(33):e2400049. PubMed ID: 38952055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in various bio-applications of bacteria-derived outer membrane vesicles.
    Sadeghi L; Mohit E; Moallemi S; Ahmadi FM; Bolhassani A
    Microb Pathog; 2023 Dec; 185():106440. PubMed ID: 37931826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outer Membrane Vesicle Vaccine Platforms.
    Micoli F; Adamo R; Nakakana U
    BioDrugs; 2024 Jan; 38(1):47-59. PubMed ID: 37796436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for
    Irene C; Fantappiè L; Caproni E; Zerbini F; Anesi A; Tomasi M; Zanella I; Stupia S; Prete S; Valensin S; König E; Frattini L; Gagliardi A; Isaac SJ; Grandi A; Guella G; Grandi G
    Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21780-21788. PubMed ID: 31591215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens.
    Lei EK; Azmat A; Henry KA; Hussack G
    Appl Microbiol Biotechnol; 2024 Feb; 108(1):232. PubMed ID: 38396192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial Outer Membrane Vesicles: From Discovery to Applications.
    Sartorio MG; Pardue EJ; Feldman MF; Haurat MF
    Annu Rev Microbiol; 2021 Oct; 75():609-630. PubMed ID: 34351789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial outer membrane vesicles in cancer: Biogenesis, pathogenesis, and clinical application.
    Li D; Zhu L; Wang Y; Zhou X; Li Y
    Biomed Pharmacother; 2023 Sep; 165():115120. PubMed ID: 37442066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial outer membrane vesicle-based cancer nanovaccines.
    Gao X; Feng Q; Wang J; Zhao X
    Cancer Biol Med; 2022 Sep; 19(9):1290-300. PubMed ID: 36172794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioengineering bacterial outer membrane vesicles as vaccine platform.
    Gerritzen MJH; Martens DE; Wijffels RH; van der Pol L; Stork M
    Biotechnol Adv; 2017 Sep; 35(5):565-574. PubMed ID: 28522212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On-Demand Vaccine Production via Dock-and-Display of Biotinylated Antigens on Bacterial Extracellular Vesicles.
    Weyant KB; Oloyede A; DeLisa MP
    Methods Mol Biol; 2024; 2843():195-216. PubMed ID: 39141302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outer membrane vesicles as platform vaccine technology.
    van der Pol L; Stork M; van der Ley P
    Biotechnol J; 2015 Sep; 10(11):1689-706. PubMed ID: 26912077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance.
    Zhu Z; Antenucci F; Villumsen KR; Bojesen AM
    mBio; 2021 Aug; 12(4):e0170721. PubMed ID: 34372691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface Mineralization of Engineered Bacterial Outer Membrane Vesicles to Enhance Tumor Photothermal/Immunotherapy.
    Chen X; Li P; Luo B; Song C; Wu M; Yao Y; Wang D; Li X; Hu B; He S; Zhao Y; Wang C; Yang X; Hu J
    ACS Nano; 2024 Jan; 18(2):1357-1370. PubMed ID: 38164903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.